4*Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies
Annals of Oncology(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络